Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy
Clinical trial NCT05063877 · UNKNOWN
Trial details
- NCT number
- NCT05063877
- Sponsor
- Equilibre Biopharmaceuticals B.V.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2022-10-11
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.